Macular Edema Nepafenac vs. Difluprednate Uveitis Trial
Status:
Terminated
Trial end date:
2020-03-31
Target enrollment:
Participant gender:
Summary
Macular edema is a condition in which there is swelling in the macula, the part of the retina
that gives you your best vision. This swelling can cause your vision to decline. When
diagnosed early and treated, you vision usually can be preserved. However, if the swelling
goes untreated for a long time, it can cause permanent vision loss.
We think that the three eye drop regimens in this study, difluprednate, difluprednate plus
nepafenac, and prednisolone acetate plus nepafenac, might be effective in treating uveitic
macular edema. Patients who enter this study are randomized to one of the three regimens and
followed for 24 weeks.